Joel F. Martin

Vorstandsvorsitzender bei

Dauntless 2, Inc.

Health Technology

Finance

Commercial Services

Profil

Joel F.
Martin was the founder of Sofinnova Investments, Inc. (1974) as President & Chief Executive Officer.
Dr. Martin was the founder of Dauntless Pharmaceuticals, Inc. (2015) as President, Chief Executive Officer & Director.
Dr. Martin is also the founder of Argonaut Technologies, Inc., Quantum Dot Corp., Intrepida Bio, Inc. Dr. Martin is currently President, Chief Executive Officer & Director at Dauntless 1, Inc. and President, Chief Executive Officer & Director at Dauntless 2, Inc. Former positions include President, Chief Executive Officer & Director at Cebix, Inc., President & Chief Executive Officer at Altair Therapeutics, Inc., Director at Hypnion, Inc., Principal at Institutional Venture Partners, and Member at Forward Ventures Services LLC (2001-2008).
Education includes a doctorate from the University of California San Diego and undergraduate and MBA degrees from the University of Michigan.

Aktive Positionen von Joel F. Martin

Unternehmen	Position	Beginn
Dauntless 2, Inc. Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations	Vorstandsvorsitzender	-
Dauntless 1, Inc. Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Vorstandsvorsitzender	-
Intrepida Bio, Inc. Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines that modulates innate immune system to fight cancer	Gründer	-

Alle aktiven Positionen von Joel F. Martin

Ehemalige bekannte Positionen von Joel F. Martin

Unternehmen	Position	Ende
Altair Therapeutics, Inc. Altair Therapeutics, Inc. Medical DistributorsDistribution Services Discovers, develops and commercializes antisense drugs	Vorstandsvorsitzender	09.03.2011
Forward Ventures Services LLC Forward Ventures Services LLC Investment ManagersFinance Forward Ventures invests in companies located in the United States. The firm targets operating in the fields on life sciences and bio pharmaceuticals sectors. It provides financing for early stage capital requirements.	Mitglied des Investmentausschusses	31.12.2008
Dauntless Pharmaceuticals, Inc. Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs	Gründer	-
Sofinnova Investments, Inc. Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements.	Vorstandsvorsitzender	-
Quantum Dot Corp. Quantum Dot Corp. BiotechnologyHealth Technology Develop biomolecular detection novel solutions intended for clinical applications	Vorstandsvorsitzender	-

Sehen Sie sich die Erfahrung von Joel F. Martin im Detail an

Ausbildung von Joel F. Martin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Joel F. Martin im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	14
Argonaut Technologies, Inc. Argonaut Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis in the development of new drugs	Commercial Services
Hypnion, Inc. Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops neuroscience drugs	Commercial Services
Quantum Dot Corp. Quantum Dot Corp. BiotechnologyHealth Technology Develop biomolecular detection novel solutions intended for clinical applications	Health Technology
Cebix, Inc. Cebix, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for complications of diabetes	Health Technology
Institutional Venture Partners Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It provides financing for growth stage capital requirements with the investment size of USD 15 - 75 millions. It also participates in follow on investments.	Finance
Sofinnova Investments, Inc. Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements.	Finance
University of California San Diego University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Forward Ventures Services LLC Forward Ventures Services LLC Investment ManagersFinance Forward Ventures invests in companies located in the United States. The firm targets operating in the fields on life sciences and bio pharmaceuticals sectors. It provides financing for early stage capital requirements.	Finance
Altair Therapeutics, Inc. Altair Therapeutics, Inc. Medical DistributorsDistribution Services Discovers, develops and commercializes antisense drugs	Distribution Services
Dauntless 1, Inc. Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Dauntless Pharmaceuticals, Inc. Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs	Retail Trade
Dauntless 2, Inc. Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations	Health Technology
Intrepida Bio, Inc. Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines that modulates innate immune system to fight cancer	Health Technology